The President of telehealth company, Pathway Health recently joined Steve Darling from Proactive Investors to discuss the company’s recent  news about the company entering into a Service Agreement with Canntab Therapeutics for the oral delivery of cannabinoids in tablet  form. 

In the interview, Wayne  Cockburn discussed the reasoning behind signing the agreement with Canntab, how Pathway is positioning for Cannabis 3.0 and what’s to come in 2022. 

To see the full interview, please click here.